Background: One third of all deaths worldwide are attributed to acute coronary syndrome. Th e thrombolysis in Myocardial Infarction Risk Score is used to assess the risk of mortality and major adverse outcomes in this population. Th is study aimed to assess and compare the morbidity and mortality diff erences rate between Saudi and non-Saudi patients with acute coronary syndrome.
INTRODUCTION
Acute coronary syndrome (ACS) describes a spectrum of myocardial ischemic conditions sharing a common etiology; ST-elevation myocardial infarction (STEMI), non ST-elevation myocardial infarction (NSTEMI) and unstable angina (UA) [1] Acute coronary syndrome is a medical emergency associated with high morbidity and mortality that necessitates prompt diagnosis and intervention [2] . One convenient method to predict mortality aft er an ACS event is the thrombolysis in myocardial infarction (TIMI) risk score. Th e TIMI risk score is readily calculated at bedside using the available clinical data at presentation to predict 30-day adverse outcomes, stratifying patients into low risk (score 0-1) and high risk (score >1) [3, 4] .
A study conducted on 279 patients visiting the emergency department concluded that TIMI score is a valid tool for assessing 30-day mortality risk [5] . Another study of 3,609 patients presented with (STEMI), showed that TIMI score has both short and long-term value in predicting patient mortality in those who underwent primary percutaneous coronary intervention [6] .
Th e Saudi and non-Saudi populations noticeably diff er in ethnicity, socioeconomic status and healthcare access. However, it is not entirely clear whether the two populations diff er in response to therapy and clinical outcomes. Th erefore, our study was designed to assess and compare the morbidity and mortality diff erences rate between Saudi and non -Saudi patients following ACS using the TIMI risk score.
MATERIALS AND METHODS
A retrospective study of adult patients diagnosed with ACS, who were admitted to Coronary Care Unit at King Abdulaziz University Hospital (KAUH) from May 2015 to May 2016. Two hundred forty-two ACS were enrolled in this study. Data was collected aft er reviewing patients' electronic fi les for clinical presentation, ECG fi ndings on admission, lab biomarkers, and primary interventions aft er coronary catheterization fi ndings, short-term and long-term outcomes. Th e primary endpoint was all-cause mortality at 30 days and 1 year, which had been calculated using the TIMI risk score. Th e secondary endpoint was major adverse cardiac events (MACE), which is a composite of myocardial infarction, stroke and the need for revascularization.
Th e TIMI risk score for STEMI patients was calculated based on seven independent risk factors, including age 65-75 years, history of diabetes mellitus, hypertension or angina, systolic blood pressure less than 100 mmHg, heart rate more than 100 beats/min, Killip class II-IV, weight less than 67 kg, anterior ST elevation or left bundle branch block and time of treatment more than 4 hours. Whereas, for NSTEMI and UA patients TIMI was calculated based Th e data were collected using data collection sheet, which was reviewed and approved by the ethical committee of KAUH. Th e data were analyzed using IBM SPSS Statistics for Windows, Version 20 (IBM Corp., Armonk, NY USA). Descriptive statistics was done with (P < 0.05) level of signifi cance.
RESULTS

ST-Elevation Myocardial Infarction Cohort
Ninety-eight cardiac patients presenting with STEMI were enrolled in this study of whom 81 (82.7%) were male, with mean age 58.4 ± 12.6, 77 (78.6%) were non-Saudi (Table  1) . Th e median TIMI score for STEMI Saudi patients was 5 and for non-Saudis was 3.5 (p = 0.6), in the non-Saudi population the results revealed that 27 (28.4%) were at low risk with a score < 2, only 5 (5.3%) cases were high-risk group with a score > 8, while most cases 63 (66.3%) had an intermediate risk score between 2-8 ( Table 2 ).
Non-Saudis had numerically higher scores than Saudis in Killip class, history of angina, anterior MI, 2 vessels and 3 vessels disease. On the other hand, the scores of Saudis were higher in hypertension, diabetes mellitus, delay in treatment > 4 hours, ejection fraction (EF) post infarct ≤ 30%, normal coronaries, single vessel disease and left main (LM) disease with no signifi cant diff erence between Saudis and non-Saudis in all variables, while the rate of left bundle branch block was signifi cantly higher among Saudis than non-Saudis (p = 0.01). Loss of follow-up was higher among non-Saudis with no signifi cant diff erence in short and long-term outcomes while the LDL and serum creatinine were higher among Saudis than non-Saudis (Table 3 and  4) .
Th e mean and median scores were only signifi cantly higher between the two groups in the infl ammatory markers measured white blood cells (WBC), hemoglobin, troponin, serum creatinin kinase (CK) and serum creatine kinase muscle/brain (CKMB) with (p = 0.01, p=0.02 & p = 0.04), respectively ( 
Unstable Angina/Non ST-Elevation Myocardial Infarction Cohort
One hundred forty-four patients presented with UA/ NSTEMI of whom 112 (77.8%) were male with mean age score 59.7 ± 11.6, 94 (65.3%) were non-Saudis. Demographic data are described in (Table 6) .
Th e median of NSTEMI score was 4.2 for Saudis versus 4.5 for non-Saudis (p = 0.4) ( Table 7) non-Saudis score was higher than Saudis in history of CAD or angina, three or more risk factors for CAD, positive cardiac markers, number of diseased vessels and LM disease, while the score of Saudis was higher in aspirin use in the last seven days prior to presentation, ST changes on ECG and EF post infarct ≤ 30% with no signifi cant diff erence between Saudis and non-Saudis in all variables except history of CAD (p = 0.03) ( Th e mean scores were higher among non-Saudi than Saudi for all biomarkers variables LDL, WBC, hemoglobin, Troponin, serum CK, serum CKMB and serum creatinine with no signifi cant diff erence for all variables except WBC count (p = 0.02) (Table 10) .
DISCUSSION
In this cohort of patients presenting with ACS, we sought to study the impact of non-Saudis nationals on outcomes using the TIMI risk score as a surrogate predictor of outcome compared to local nationals. In a previous study done by AlFaleh et al. [7] , non-Saudis had poor outcomes compared to Saudis with a higher rate of death, cardiogenic shock and heart failure, more than 2,031 patients were recruited from a total of 5,055 patients as part of the Saudi Project for Assessment of Coronary Events (SPACE) registry. Saudis tend to be more diabetics, present with STEMI and receive percutaneous coronary intervention (PCI) more frequently than non-Saudis who are typically treated more with fi brinolysis (initial presentation to non-PCI centers) and had more NSTEMI presentations. Th e authors concluded that despite similar hospital-based treatment the outcomes were diff erent due to issues related to health care access and unequal health coverage. Th e issue of unequal insurance coverage among expatriates manpower raises a major concern, despite the government mandates that every foreign worker should have adequate medical coverage before starting his work in the Kingdom, it appears that the premium coverage is variable and solely dependent on the insurer, hence some do not have coverage for a relatively high price medical care like the one needed for myocardial infarction even if it is lifesaving, as this premium coverage restricts eligibility to few hospitals, most are not ACS referral centers and are not catheterization-laboratory equipped facilities [7] .
In our hospital, we decided to look at the outcomes of patients based on their TIMI score to assess any diff erences among Saudis and non-Saudis regardless of their initial treatment, we were able to identify more than 200 patients, the majority were male, and they were in their late 50s.
When applying the TIMI score of STEMI and NSTEMI/ UA on these patients, no diff erences in overall score were identifi ed. More importantly, the rate of death and MACE between the two populations was similar at 30 days and 1 year, respectively. Th e only signifi cant diff erence was in the infl ammatory markers as non-Saudis tend to have higher cardiac enzymes (troponin and creatine kinase) and white cell counts at presentation, the latter supports the previous study that non-Saudis have delayed presentations related to health care coverage and access. However, Saudis numerically have more than 4 hours delay when presenting with STEMI than non-Saudis (52% vs. 42%) likely related to understanding the signifi cance of symptoms and the need of timely access to health care. Prior history of CAD was more commonly encountered in the non-Saudi population and that is probably related to a previous diagnosis with or without adequate treatment.
Despite our eff orts to control the confounders, the study has its own limitations, the small number of patients enrolled compared to registry lead to underpowered analysis to look for subtle diff erences. Additionally, the limitations inherent with retrospective analysis, and the use of a scoring system, and its relevant applicability on diff erent populations. Finally, there were some patients from the non-Saudi population who have lost their followups, making it diffi cult to understand their outcomes.
Both Saudi and non-Saudi patients have their own challenges and diffi culties when presenting with an acute coronary event. At our hospital, we apply "open door" policy to all comers with such diagnoses and try to shorten the time of ischemia to the minimum using pharmacoinvasive and or primary PCI approaches dictated by the most updated guidelines, with an average door to needle time less than 26 minutes, door to balloon time less than 79-85 minutes and overall mortality of less than 2% among all ACS comers, that may explain the impact of this policy on ACS patients and its role in improving the outcomes regardless to which TIMI risk group they belong to. Finally, there were more non-Saudis with acute coronary events visiting the university hospital than Saudis likely due to the limited accessibility options the expats have with other local hospitals, either due to elegibility related issues or fi nancial constraints.
CONCLUSION
Th e TIMI risk score did not statistically diff erentiate between Saudi and non-Saudi patients. However, biomarkers did diff erentiate between the two populations, as non-Saudis patients tend to have higher levels of troponin, serum creatine kinase and white blood cell count, which might be contributed to delayed presentation and health care access issues. Th e type of tertiary center ACS patients present to, may play a major role in improving the outcomes regardless to which TIMI risk group they belong to.
